Company intelligence / Profile preview

Api Company

L'Aquila, Italy

Ownership: Private
Development stage: Other

Overview

API (Active Pharmaceutical Ingredients) is an Italian pharmaceutical company specializing in the development and manufacturing of high-quality active pharmaceutical ingredients for the global market. The company operates as a Contract Development and Manufacturing Organization (CDMO), providing services ranging from process development to large-scale commercial production of small molecule APIs. With a strong focus on regulatory compliance and quality standards, API serves a diverse clientele including major multinational pharmaceutical firms and generic drug manufacturers. Their expertise lies in complex chemical synthesis and the production of niche or difficult-to-manufacture compounds.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Api Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Api Company.

Explore the full profile